Patents by Inventor Sharon Johnstone

Sharon Johnstone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160058704
    Abstract: Compositions which comprise liposomes having controlled release of a platinum agent are useful in achieving enhanced therapeutic effects particularly when these drugs are administered in combination with other therapeutic agents.
    Type: Application
    Filed: November 3, 2015
    Publication date: March 3, 2016
    Applicant: CELATOR PHARMACEUTICALS INC.
    Inventors: Paul TARDI, Sharon JOHNSTONE, Lawrence MAYER
  • Patent number: 8486924
    Abstract: Nanoparticulate formulations for delivery of taxane conjugate prodrug formed from a taxane coupled to a hydrophobic moiety through a glycolate linker are described.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: July 16, 2013
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Steven M. Ansell, Sharon Johnstone, Paul Tardi, Lawrence Mayer
  • Patent number: 8431806
    Abstract: Compositions which comprise an anthracycline agent, and a cytidine analog are encapsulated in liposomal carriers. The preferred anthracycline agent is selected from the group of daunorubicin, doxorubicin, and idarubicin, while the preferred cytidine analog is selected from the group of cytarabine, gemcitabine, or 5-azacytidine. The combination of the anthracycline agent and cytidine analog encapsulated in said liposomal carriers are useful in achieving a drug retention and a sustained drug release for each therapeutic agent.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: April 30, 2013
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Lawrence Mayer, Sharon Johnstone, Troy Harasym
  • Publication number: 20120009252
    Abstract: Compositions which comprise an anthracycline agent, and a cytidine analog are encapsulated in liposomal carriers. The preferred anthracycline agent is selected from the group of daunorubicin, doxorubicin, and idarubicin, while the preferred cytidine analog is selected from the group of cytarabine, gemcitabine, or 5-azacytidine. The combination of the anthracycline agent and cytidine analog encapsulated in said liposomal carriers are useful in achieving a drug retention and a sustained drug release for each therapeutic agent.
    Type: Application
    Filed: September 20, 2011
    Publication date: January 12, 2012
    Applicant: CELATOR PHARMACEUTICALS, INC.
    Inventors: Lawrence MAYER, Sharon Johnstone, Troy Harasym
  • Publication number: 20120003294
    Abstract: Compositions which comprise liposomes having controlled release of a platinum agent are useful in achieving enhanced therapeutic effects particularly when these drugs are administered in combination with other therapeutic agents.
    Type: Application
    Filed: August 14, 2008
    Publication date: January 5, 2012
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Paul Tardi, Sharon Johnstone, Lawrence Mayer
  • Patent number: 8022279
    Abstract: Compositions which comprise an anthracycline agent, and a cytidine analog are encapsulated in liposomal carriers. The preferred anthracycline agent is selected from the group of daunorubicin, doxorubicin, and idarubicin, while the preferred cytidine analog is selected from the group of cytarabine, gemcitabine, or 5-azacytidine. The combination of the anthracycline agent and cytidine analog encapsulated in said liposomal carriers are useful in achieving a drug retention and a sustained drug release for each therapeutic agent.
    Type: Grant
    Filed: April 22, 2005
    Date of Patent: September 20, 2011
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Lawrence Mayer, Sharon Johnstone, Troy Harasym
  • Publication number: 20100331290
    Abstract: Nanoparticulate formulations for delivery of taxane conjugate prodrug formed from a taxane coupled to a hydrophobic moiety through a glycolate linker are described.
    Type: Application
    Filed: November 26, 2008
    Publication date: December 30, 2010
    Inventors: Steven M. Ansell, Sharon Johnstone, Paul Tardi, Lawrence Mayer
  • Patent number: 7744921
    Abstract: This invention relates to encapsulation of drugs and other agents into liposomes.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: June 29, 2010
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Paul Tardi, Sharon Johnstone, Murray Webb, Marcel Bally, Sheela Abraham
  • Publication number: 20090148506
    Abstract: Provided herein are liposomal compositions comprising a therapeutic agent having a protonatable amino group and a secondary or tertiary amine, and methods for encapsulating such therapeutic agents. In one aspect, the present invention relates to liposomal formulations comprising irinotecan in a triethanolamine solution, and optionally comprising copper gluconate, and methods for preparing the same.
    Type: Application
    Filed: December 22, 2006
    Publication date: June 11, 2009
    Inventors: Awa Dicko, Paul Tardi, Lawrence Mayer, Sharon Johnstone
  • Publication number: 20090074848
    Abstract: Compositions which comprise delivery vehicles having stably associated therewith a cytidine analog and a platinum agent are useful in achieving enhanced therapeutic effects when combinations of these drugs are administered.
    Type: Application
    Filed: September 19, 2006
    Publication date: March 19, 2009
    Inventors: Sharon Johnstone, Pierrot Harvie, Paul Tardi, Troy Harasym, Lawrence Mayer
  • Publication number: 20080107722
    Abstract: This invention relates to encapsulation of drugs and other agents into preformed delivery vehicles.
    Type: Application
    Filed: November 18, 2005
    Publication date: May 8, 2008
    Inventors: Paul Tardi, Murray Webb, Sharon Johnstone, Pierrot Harvie, Lawrence Mayer
  • Publication number: 20080044464
    Abstract: This invention relates to encapsulation of drugs and other agents into liposomes.
    Type: Application
    Filed: August 20, 2007
    Publication date: February 21, 2008
    Inventors: Paul TARDI, Sharon Johnstone, Murray Webb, Marcel Bally, Sheela Abraham
  • Publication number: 20070286897
    Abstract: Compositions which comprise an anthracycline agent, and a cytidine analog are encapsulated in liposomal carriers. The preferred anthracycline agent is selected from the group of daunorubicin, doxorubicin, and idarubicin, while the preferred cytidine analog is selected from the group of cytarabine, gemcitabine, or 5-azacytidine. The combination of the anthracycline agent and cytidine analog encapsulated in said liposomal carriers are useful in achieving a drug retention and a sustained drug release for each therapeutic agent.
    Type: Application
    Filed: April 22, 2005
    Publication date: December 13, 2007
    Applicant: CELATOR PHARMACEUTICALS, INC.
    Inventors: Lawrence Mayer, Sharon Johnstone, Troy Harasym
  • Patent number: 7238367
    Abstract: This invention relates to encapsulation of drugs and other agents into liposomes.
    Type: Grant
    Filed: October 3, 2002
    Date of Patent: July 3, 2007
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Paul Tardi, Sharon Johnstone, Murray Webb, Marcel Bally, Sheela Abraham
  • Publication number: 20060193902
    Abstract: Compositions and methods for stabilizing an active agent containing one or more actone rings. The compositions, including pharmaceutical compositions, ensure that the lactone ring of the active agent is stabilized in the active, ring-closed form due to the inclusion of a transition metal ion.
    Type: Application
    Filed: April 2, 2004
    Publication date: August 31, 2006
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Paul Tardi, Sharon Johnstone
  • Publication number: 20060193904
    Abstract: This invention relates to encapsulation of drugs and other agents into liposomes.
    Type: Application
    Filed: October 21, 2005
    Publication date: August 31, 2006
    Inventors: Paul Tardi, Sharon Johnstone, Murray Webb, Marcel Bally, Sheela Abraham
  • Publication number: 20040265368
    Abstract: Compositions which comprise liposomes having stably associated therewith a camptothecin and a fluoropyrimidine are useful in achieving enhanced therapeutic effects when combinations of these drugs are administered.
    Type: Application
    Filed: April 2, 2004
    Publication date: December 30, 2004
    Inventors: Lawrence Mayer, Marcel Bally, Murray Webb, Paul Tardi, Sharon Johnstone
  • Publication number: 20030091621
    Abstract: This invention relates to encapsulation of drugs and other agents into liposomes.
    Type: Application
    Filed: October 3, 2002
    Publication date: May 15, 2003
    Inventors: Paul Tardi, Sharon Johnstone, Murray Webb, Marcel Bally, Sheela Abraham